Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delong Chen

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of Ethnopharmacology|March 1, 2021
Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validationQi He, Junzheng Yang, Gangyu Zhang, et al.
Scientific Reports|December 31, 2024
Arctiin alleviates knee osteoarthritis by suppressing chondrocyte oxidative stress induced by accumulated iron via AKT/NRF2/HO-1 signaling pathwayJunzheng Yang, Delong Chen, Qi He, et al.
Journal of Cellular Physiology|November 19, 2021
Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathwaysGang Wang, Kai Chen, Chao Ma, et al.
JACC. Cardiovascular Interventions|February 22, 2024
Fractional Flow Reserve-Guided Drug-Coated Balloon vs Drug-Eluting Stent for de Novo Non-Small Coronary LesionsDelong Chen, Abuduwufuer Yidilisi, Yuxuan Zhang, et al.
Frontiers in Pharmacology|January 5, 2024
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activityJianbo He, Kai Chen, Tiancheng Deng, et al.
Frontiers in Pharmacology|October 11, 2021
Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS ActivityJianbo He, Kai Chen, Tiancheng Deng, et al.
JACC. Asia|December 4, 2025
Diabetes and ALDH2 Gene Polymorphism on Post-Ablation Atrial Fibrillation RecurrenceJunyan Jin, Ningjing Qian, Ying Gao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Thiaplakortone B attenuates RANKL-induced NF-κB and MAPK signaling and dampens OVX-induced bone loss in miceQingqing Wang, Delong Chen, Yining Wang, et al.
JACC. Cardiovascular Interventions|August 8, 2024
Prognostic Value of Coronary Angiography-Derived Index of Microcirculatory Resistance in Non-ST-Segment Elevation Myocardial Infarction PatientsYuxuan Zhang, Jun Pu, Tiesheng Niu, et al.
Cardiovascular Diabetology|August 16, 2024
Combined risk estimates of diabetes and coronary angiography-derived index of microcirculatory resistance in patients with non-ST elevation myocardial infarctionDelong Chen, Yuxuan Zhang, Abuduwufuer Yidilisi, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of Ethnopharmacology|March 1, 2021
Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validationQi He, Junzheng Yang, Gangyu Zhang, et al.
Scientific Reports|December 31, 2024
Arctiin alleviates knee osteoarthritis by suppressing chondrocyte oxidative stress induced by accumulated iron via AKT/NRF2/HO-1 signaling pathwayJunzheng Yang, Delong Chen, Qi He, et al.
Journal of Cellular Physiology|November 19, 2021
Roburic acid attenuates osteoclastogenesis and bone resorption by targeting RANKL-induced intracellular signaling pathwaysGang Wang, Kai Chen, Chao Ma, et al.
JACC. Cardiovascular Interventions|February 22, 2024
Fractional Flow Reserve-Guided Drug-Coated Balloon vs Drug-Eluting Stent for de Novo Non-Small Coronary LesionsDelong Chen, Abuduwufuer Yidilisi, Yuxuan Zhang, et al.
Frontiers in Pharmacology|January 5, 2024
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activityJianbo He, Kai Chen, Tiancheng Deng, et al.
Frontiers in Pharmacology|October 11, 2021
Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS ActivityJianbo He, Kai Chen, Tiancheng Deng, et al.
JACC. Asia|December 4, 2025
Diabetes and ALDH2 Gene Polymorphism on Post-Ablation Atrial Fibrillation RecurrenceJunyan Jin, Ningjing Qian, Ying Gao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Thiaplakortone B attenuates RANKL-induced NF-κB and MAPK signaling and dampens OVX-induced bone loss in miceQingqing Wang, Delong Chen, Yining Wang, et al.
JACC. Cardiovascular Interventions|August 8, 2024
Prognostic Value of Coronary Angiography-Derived Index of Microcirculatory Resistance in Non-ST-Segment Elevation Myocardial Infarction PatientsYuxuan Zhang, Jun Pu, Tiesheng Niu, et al.
Cardiovascular Diabetology|August 16, 2024
Combined risk estimates of diabetes and coronary angiography-derived index of microcirculatory resistance in patients with non-ST elevation myocardial infarctionDelong Chen, Yuxuan Zhang, Abuduwufuer Yidilisi, et al.
Pageof 7